ADPTAdaptive Biotechnologies Corp

Nasdaq adaptivebiotech.com


$ 4.42 $ 0.09 (1.96 %)    

Tuesday, 06-Aug-2024 12:02:33 EDT
QQQ $ 444.01 $ 6.21 (1.42 %)
DIA $ 391.62 $ 4.57 (1.18 %)
SPY $ 526.29 $ 6.77 (1.3 %)
TLT $ 97.45 $ -0.59 (-0.6 %)
GLD $ 220.74 $ -0.71 (-0.32 %)
$ 4.32
$ 4.34
$ 4.42 x 200
-- x --
$ 4.30 - $ 4.50
$ 2.28 - $ 6.96
2,033,226
na
636.83M
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-14-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-15-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-12-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-6

JP Morgan analyst Rachel Vatnsdal maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price ta...

 adaptive-biotechnologies-q2-2024-gaap-eps-031-beats-033-estimate-sales-43190m-beat-38664m-estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate...

 adaptive-biotechnologies-says-its-next-generation-sequencing-based-clonoseq-test-for-measurable-residual-disease-assessment-will-be-included-in-several-oral-and-poster-presentations-at-american-society-of-clinical-oncology-annual-meeting

The meeting will be taking place from May 31-June 4 in Chicago. Company will also present at the European Hematology Associatio...

 adaptive-biotechnologies-q1-2024-gaap-eps-033-beats-035-estimate-sales-41873m-beat-38784m-estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate...

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 btig-maintains-buy-on-adaptive-biotechnologies-lowers-price-target-to-5

BTIG analyst Mark Massaro maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and lowers the price target from $6 to...

 adaptive-biotechnologies-names-new-cfo-preserves-strong-capital-position

Adaptive Biotechnologies announces strategic restructuring to enhance independence and financial strength.

 adaptive-biotechnologies-provides-strategic-review-update-and-announces-preliminary-q1-2024-revenue-of-41m-43m-vs-3821m-est

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetic...

 adaptive-biotechnologies-q4-2023-adj-eps-030-beats-033-estimate-sales-4578m-miss-4846m-estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate...

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION